Remicade News
Most Popular Remicade Story
MAbs are hottest segment of biotech industry
Looking for the hottest segment of the biotech industry? Then take a look at monoclonal antibodies (mAbs). A new Datamonitor report projects 14 percent annual growth in the market for the antibody... Read more...
Latest Headlines
- October 3, 2008
- November 8, 2007
- October 12, 2007
- February 1, 2007
- October 26, 2006
- August 13, 2006
- March 8, 2006
- December 19, 2005
- October 13, 2005
- August 15, 2005
- August 11, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
